Status:
COMPLETED
Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine adherence to cardio-oncology consultation.
Detailed Description
The purpose of this study is to evaluate patient participation in a plan to improve heart health after radiation therapy by having a cardio-oncology assessment early during cancer treatment. Cardiolog...
Eligibility Criteria
Inclusion
- Any stage (I-IV) malignancy being treated with high dose (≥30 Gy) radiotherapy where the heart is in the treatment field.
- Have Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2.
- Planning to receive standard of care radiotherapy treatments.
- Access to a smart device that has the capability to sync to the devices.
- Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
- Ability to read, write and understand English.
Exclusion
- Known allergy to surgical steel or elastomer/rubber.
- Heart attack within 6 months prior to study enrollment.
- Severe and/or active scleroderma or systemic lupus erythematosus.
Key Trial Info
Start Date :
October 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 16 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05403736
Start Date
October 7 2022
End Date
June 16 2023
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Clinical Trials Office
Los Angeles, California, United States, 90048